Enanta Pharmaceuticals (ENTA) Preferred Dividend Payments (2012 - 2013)
Enanta Pharmaceuticals' (ENTA) quarterly Preferred Dividend Payments came in at -$5.1 million in Q3 2013, down 479.28% YoY from $1.3 million in Q3 2012, and down 506.11% on a QoQ basis from $1.2 million in Q1 2013.
Enanta Pharmaceuticals (ENTA) Preferred Dividend Payments (2012 - 2013) Analysis & Trends
Enanta Pharmaceuticals (ENTA) has 2 years of Preferred Dividend Payments data on file, last reported at -$5.1 million in Q3 2013.
- Quarterly Preferred Dividend Payments fell 479.28% year-over-year to -$5.1 million in Q3 2013, while the trailing twelve-month figure through Sep 2013 was $15.0 million (changed N/A YoY) and the FY2013 annual result came in at -$2.5 million, down 147.07% from the prior year.
- Preferred Dividend Payments retreated to -$5.1 million in Q3 2013, from $1.2 million in the prior quarter.
- In the past five years, Preferred Dividend Payments ranged from a high of $28.2 million in Q1 2012 to a low of -$5.1 million in Q3 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Enanta Pharmaceuticals | 383.29 Mn | 193.78 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2013 | -5.05 Mn |
| Mar 31, 2013 | 1.24 Mn |
| Dec 31, 2012 | 18.81 Mn |
| Sep 30, 2012 | 1.33 Mn |
| Jun 30, 2012 | 1.33 Mn |
| Mar 31, 2012 | 28.15 Mn |